From slight tremor in a single limb, to stiffness on both sides and slowness of movement, then to balance impairment and frequent falls, and finally to being bedridden. Parkinson’s disease traps a once energetic person within a rigid shell and plunges the entire family into the long-term burden of care.In a pressurized environment, the concentration of oxygen dissolved in the blood increases significantly, allowing it to penetrate directly through the blood-brain barrier and deeply reoxygenate hypoxic neurons. This can effectively improve motor function, cognitive ability, sleep quality, and emotional state in patients with Parkinson’s disease.
What is Parkinson’s Disease?
Parkinson’s disease is the second most common neurodegenerative disease in the world, second only to Alzheimer’s disease. The core pathology of Parkinson’s disease is the progressive loss of dopaminergic neurons in the substantia nigra. These neurons have extremely high energy demands and are extremely sensitive to hypoxia. Chronic hypoxia in brain tissue exacerbates oxidative stress, induces neuroinflammation, and promotes the aggregation of alpha-synuclein, thereby accelerating the apoptosis of dopaminergic neurons. The motor impairments caused by the disease itself reduce breathing depth and activity levels, further worsening systemic hypoxia.
The clinical manifestations of Parkinson’s disease are divided into two dimensions: motor symptoms and non-motor symptoms. Motor symptoms have distinct characteristics. Resting tremor is the most common initial symptom, presenting as a pill-rolling motion of the fingers, worsening with stress and disappearing during sleep. Rigidity causes cogwheel or lead-pipe resistance during limb movement, and reduced facial expression results in masked face. Bradykinesia slows down daily movements, making buttoning clothes, writing, getting up, and turning around difficult. Postural instability leads to hesitation in starting to walk and a propulsive gait, increasing the risk of falls.
Sleep disorders are extremely common, including insomnia, REM sleep behavior disorder, and daytime sleepiness. Cognitive impairment can progress from mild cognitive impairment to Parkinson’s disease dementia. Psychiatric symptoms include depression, anxiety, and apathy. Autonomic dysfunction manifests as constipation, orthostatic hypotension, and urinary abnormalities.
The primary population affected by Parkinson’s disease is middle-aged and elderly people, with incidence increasing significantly with age. However, early-onset Parkinson’s disease is not rare in recent years, suggesting an interaction between genetic and environmental factors. Additionally, individuals with long-term exposure to pesticides or heavy metals, or those with a family history of the disease in a first-degree relative, are at higher risk.
The harm of Parkinson’s disease is comprehensive and irreversible. Progressive loss of motor ability, from hand tremor to difficulty moving. Continuous decline in cognitive function, affecting decision-making and memory. Worsening depression and anxiety, leading to a sharp decline in quality of life. In advanced stages, being bedridden, having difficulty swallowing, and experiencing recurrent lung infections may ultimately lead to death from complications. Therefore, the necessity of active intervention for Parkinson’s disease lies not only in slowing the decline of motor function but also in protecting cognition, stabilizing mood, and maintaining life with dignity.
How Does a Hyperbaric Oxygen Chamber Treat Parkinson’s Disease?
Hyperbaric oxygen chamber therapy is a physical therapy involving breathing high-concentration oxygen in an environment with pressure higher than atmospheric pressure. When applied to the adjunctive management of Parkinson’s disease, by physically significantly increasing oxygen partial pressure in brain tissue, it produces positive effects targeting the core pathological links of Parkinson’s disease: brain tissue hypoxia, mitochondrial dysfunction, neuroinflammation, and oxidative stress.
Improving brain tissue oxygen supply protects dopaminergic neurons
Hyperbaric oxygen can significantly increase oxygen partial pressure in the substantia nigra, providing ample energy to vulnerable dopaminergic neurons and delaying their apoptotic process.
Inhibiting neuroinflammation and reducing oxidative stress
Hyperbaric oxygen can reduce the release of pro-inflammatory cytokines and enhance the activity of antioxidant enzymes. After HBOT, levels of inflammatory markers such as YKL-40 and osteopontin in patients are significantly reduced, SOD levels are increased, LPO levels are decreased, and BDNF and GABA levels are significantly elevated.
Improving motor function and delaying disease progression
After HBOT, patients’ UPDRS Part III scores are reduced on average, and Hoehn-Yahr stages are reduced on average, effectively controlling disease severity.
Improving sleep quality and reducing daytime sleepiness
Hyperbaric oxygen can significantly improve sleep efficiency, total sleep time, and slow-wave sleep time, reduce the frequency of awakenings, and improve PSQI and ESS scores.
| Indicator | Conventional Medication Outcome | HBOT Combination Therapy Outcome | Core Significance |
| Overall Treatment Efficacy Rate | Limited efficacy, some patients show no significant improvement | Overall efficacy rate significantly higher than conventional treatment | Significantly enhances clinical efficacy |
| Motor Function (UPDRS III) | Continues to decline with disease progression | Motor function score significantly improved | Slows the decline of motor function |
| Cognitive Function (MoCA) | Cognitive decline difficult to reverse | Cognitive score significantly higher than conventional treatment group | Protects cognitive function |
| Sleep Quality (PSQI) | Prominent sleep disorders, difficult to improve | All sleep quality indicators significantly improved | Improves sleep architecture, reduces daytime sleepiness |
| Depression/Anxiety Scores | High proportion of comorbid mood disorders | HAMD and HAMA scores significantly improved | Stabilizes mood, reduces psychological burden |
| Neuroinflammation and Oxidative Stress | Elevated pro-inflammatory factors, decreased antioxidant capacity | BDNF, GABA, and SOD levels significantly increased | Promotes neural repair, inhibits oxidative stress |
Hyperbaric oxygen is an adjunctive, supportive treatment for Parkinson’s disease and must not replace standard dopamine replacement therapy. Its core value lies in: delaying disease progression, improving motor and non-motor symptoms, and enhancing quality of life.
References:
Bu S, et al. Hyperbaric Oxygen Therapy Improves Motor Symptoms, Sleep, and Cognitive Dysfunctions in Parkinson’s Disease. Dement Geriatr Cogn Disord. 2025;54(3):187-200.
Pan Z, et al. Effect of hyperbaric oxygen therapy for non-motor symptoms among patients with Parkinson’s disease: A systematic review and meta-analysis. Clin Rehabil. 2025;39(3):281-294.
Tan W, et al. Efficacy of hyperbaric oxygen therapy as an adjunct therapy in the treatment of sleep disorders among patients with Parkinson’s disease: a meta-analysis. Front Neurol. 2024;15:1328911.
What Are the Advantages of a Home Hyperbaric Chamber?
For Parkinson’s disease, a neurodegenerative disease requiring lifelong management, the continuity, regularity, and comfort of rehabilitation are crucial. Being able to conveniently receive deep neurological support at home greatly enhances long-term rehabilitation outcomes and quality of life. Kingshare home hyperbaric chambers bring a professional brain health support system into the home, allowing patients to continuously recharge their fatigued neurons in a familiar, relaxing environment.
Three-in-one main unit integrates three major functions: air, oxygen, and air conditioning. Traditional oxygen chambers require external oxygen concentrators and air conditioning units, taking up space and being troublesome to install. We have innovatively integrated these three core functions into a single main unit, allowing one-press start and immediate use, providing maximum convenience for Parkinson’s patients with limited mobility.
Fully modular integrated structure simplifies maintenance. We have divided the entire machine into multiple highly integrated functional modules, including air pressure regulation, oxygen supply circulation, and electrical control. When a certain unit ages or needs upgrading, only a single module needs to be plugged or unplugged via standardized interfaces, without requiring complete machine disassembly and return to the factory, greatly reducing after-sales maintenance costs.
Built-in negative oxygen ion ecological purification system. The chamber continuously releases high concentrations of negative oxygen ions, actively adsorbing dust and destroying bacterial activity, achieving consumable-free air self-purification. High concentrations of negative ions help regulate central nervous system excitability, helping patients enter a deeper state of relaxation more quickly during oxygen therapy.
BIBS breathing system improves oxygen inhalation efficiency. The dual-tube circulation design ensures that inhaled oxygen is of high purity, while exhaled carbon dioxide is promptly removed, making every breath efficient and pure.
Customizable red light bed. Red light photobiomodulation works synergistically with hyperbaric oxygen to further improve microcirculation, promote nerve cell repair and energy metabolism, and accelerate the recovery of brain function.
Real Case: The Journey of Quelling Tremors
John, a 68-year-old retired teacher from the United Kingdom, had been troubled by Parkinson’s disease for six years. His resting tremor in his right hand was progressively worsening, making it difficult to hold a cup or write. His movements were slow, and he needed a long time to muster the energy to start moving. His nighttime sleep quality was extremely poor, with frequent nightmares and loud yelling. What distressed him most was that he began to experience freezing of gait, feeling as if nailed to the spot when crossing a threshold.
He had been taking levodopa for a long time, but its effectiveness was diminishing over time, and the wearing-off phenomenon became increasingly apparent. At a neuroscience conference, his attending physician mentioned the research progress of hyperbaric oxygen in the adjunctive treatment of Parkinson’s disease. After detailed consideration, John decided to try introducing hyperbaric oxygen as a daily rehabilitation method.
First month of conditioning: John underwent 5 conditioning sessions per week (1.5 ATA, 60 minutes each). After two weeks, his most noticeable change was improved sleep quality. Nighttime yelling decreased, and his daytime mental state improved.
After two months of conditioning: The amplitude of his right-hand tremor had significantly decreased, and he could hold a cup steadily to drink water. The frequency of freezing of gait episodes reduced from multiple times per day to occasional.
After three months of conditioning: He had completed approximately 40 sessions. In his neurologist’s assessment, both his motor function scores and cognition had significantly improved. He picked up his long-unused fountain pen again. Although not as good as before, it was enough to bring tears to his eyes.
The hyperbaric oxygen chamber is a neural guardian that penetrates deeply into the brain’s microenvironment. By enhancing the body’s most fundamental level of oxygenation, it delivers life-giving energy to dying dopaminergic neurons. The best treatment is not to rescue after neurons have died, but to give them enough oxygen to live while they are still alive, sending calming signals to uncontrolled inflammation, and delivering stabilizing commands to trembling limbs.
Kingshare is a hyperbaric oxygen chamber factory with 10 years of production experience. We provide turnkey services from design to delivery. If you have any needs for hyperbaric oxygen chambers, please contact us.
